SC
Salvatore Calabrese
Chief Financial Officer
Salvatore CalabreseChief Financial Officer
Salvatore Calabrese insider trades: Gain Therapeutics (GANX) SEC Form 4 filings
Chief Financial Officer, Gain Therapeutics 3 Form 4 filings
3
Form 4 filings
last Mar 27, 2023
2
Grants and awards
filings
1
Company
Companies
Where Salvatore reports to the SEC
About Salvatore Calabrese's insider trades
Salvatore Calabrese is Chief Financial Officer at Gain Therapeutics (GANX). Salvatore has not reported an open-market purchase or sale.
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GANX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.